These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 2848467)

  • 41. Neopeptide antibiotics that function as opsonins and membrane-permeabilizing agents for gram-negative bacteria.
    Tsubery H; Yaakov H; Cohen S; Giterman T; Matityahou A; Fridkin M; Ofek I
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3122-8. PubMed ID: 16048913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-Function Studies of Polymyxin B Lipononapeptides.
    Gallardo-Godoy A; Hansford KA; Muldoon C; Becker B; Elliott AG; Huang JX; Pelingon R; Butler MS; Blaskovich MAT; Cooper MA
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30717415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the susceptibility test of polymyxin B using the commercial test Policimbac®.
    Dalmolin TV; Carneiro MDS; de Castro LP; Volpato FCZ; Wink PL; de Lima-Morales D; Barth AL
    Braz J Microbiol; 2020 Sep; 51(3):1135-1137. PubMed ID: 32198730
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indole and (E)-2-hexenal, phytochemical potentiators of polymyxins against Pseudomonas aeruginosa and Escherichia coli.
    Kubo A; Lunde CS; Kubo I
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1438-41. PubMed ID: 8726016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polymyxin B nonapeptide inhibits mating in Saccharomyces cerevisiae.
    Boguslawski G
    Antimicrob Agents Chemother; 1986 Feb; 29(2):330-2. PubMed ID: 3013083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-terminal modifications of Polymyxin B nonapeptide and their effect on antibacterial activity.
    Tsubery H; Ofek I; Cohen S; Fridkin M
    Peptides; 2001 Oct; 22(10):1675-81. PubMed ID: 11587796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergistic combinations of polymyxins.
    Lenhard JR; Nation RL; Tsuji BT
    Int J Antimicrob Agents; 2016 Dec; 48(6):607-613. PubMed ID: 27865626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of polymyxin B nonapeptide on daptomycin permeability and cell surface properties in Pseudomonas aeruginosa, Escherichia coli, and Pasteurella multocida.
    Morris CM; George A; Wilson WW; Champlin FR
    J Antibiot (Tokyo); 1995 Jan; 48(1):67-72. PubMed ID: 7868392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polycations sensitize enteric bacteria to antibiotics.
    Vaara M; Vaara T
    Antimicrob Agents Chemother; 1983 Jul; 24(1):107-13. PubMed ID: 6414364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
    Evans ME; Feola DJ; Rapp RP
    Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside.
    Zavascki AP
    Expert Rev Anti Infect Ther; 2014 May; 12(5):531-3. PubMed ID: 24666285
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of an adjuvant that resensitizes polymyxin B-resistant bacteria.
    Mahdavi M; Findlay BL
    Bioorg Med Chem; 2024 Jan; 97():117541. PubMed ID: 38096681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel derivatives of polymyxins.
    Vaara M
    J Antimicrob Chemother; 2013 Jun; 68(6):1213-9. PubMed ID: 23412346
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B.
    Landman D; Bratu S; Alam M; Quale J
    J Antimicrob Chemother; 2005 Jun; 55(6):954-7. PubMed ID: 15883174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro evaluation of the antimicrobial activity of meropenem in combination with polymyxin B and gatifloxacin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Guelfi KC; Tognim MC; Cardoso CL; Gales AC; Carrara-Marrone FE; Garcia LB
    J Chemother; 2008 Apr; 20(2):180-5. PubMed ID: 18467243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The outer membrane as the penetration barrier against mupirocin in gram-negative enteric bacteria.
    Vaara M
    J Antimicrob Chemother; 1992 Feb; 29(2):221-2. PubMed ID: 1506338
    [No Abstract]   [Full Text] [Related]  

  • 58. Rifaximin combined with polymyxins: A potential regimen for selective decontamination of multidrug-resistant bacteria in the digestive tract?
    Betts JW; Phee LM; Wareham DW
    J Glob Antimicrob Resist; 2016 Mar; 4():11-15. PubMed ID: 27436386
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inactivation of Polymyxin by Hydrolytic Mechanism.
    Yin J; Wang G; Cheng D; Fu J; Qiu J; Yu Z
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reaction-Induced Self-Assembly of Polymyxin Mitigates Cytotoxicity and Reverses Drug Resistance.
    Hu X; Li D; Li H; Piao Y; Wan H; Zhou T; Karimi M; Zhao X; Li Y; Shi L; Liu Y
    Adv Mater; 2024 Sep; 36(36):e2406156. PubMed ID: 39022883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.